CTI BioPharma Statistics Share Statistics CTI BioPharma has 131.88M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 131.88M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 99.89M Failed to Deliver (FTD) Shares 990,029 FTD / Avg. Volume 17.49%
Short Selling Information The latest short interest is 13.43M, so 0% of the outstanding
shares have been sold short.
Short Interest 13.43M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 6.17
Valuation Ratios The PE ratio is -7.57 and the forward
PE ratio is null.
CTI BioPharma's PEG ratio is
0.26.
PE Ratio -7.57 Forward PE n/a PS Ratio 12.78 Forward PS n/a PB Ratio -39.22 P/FCF Ratio -6.49 PEG Ratio 0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CTI BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.23,
with a Debt / Equity ratio of -2.84.
Current Ratio 1.23 Quick Ratio 1.22 Debt / Equity -2.84 Debt / EBITDA -0.63 Debt / FCF -0.47 Interest Coverage -6.07
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $424.79K Profits Per Employee $-716.86K Employee Count 127 Asset Turnover 0.43 Inventory Turnover 4.79
Taxes Income Tax -1.95M Effective Tax Rate 2.1%
Stock Price Statistics The stock price has increased by 0.11% in the
last 52 weeks. The beta is 0.83, so CTI BioPharma's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change 0.11% 50-Day Moving Average 7.44 200-Day Moving Average 5.87 Relative Strength Index (RSI) 83.62 Average Volume (20 Days) 5,661,603
Income Statement In the last 12 months, CTI BioPharma had revenue of 53.95M
and earned -91.04M
in profits. Earnings per share was -0.79.
Revenue 53.95M Gross Profit 50.43M Operating Income -79.8M Net Income -91.04M EBITDA -79.85M EBIT -79.85M Earnings Per Share (EPS) -0.79
Full Income Statement Balance Sheet The company has 30.42M in cash and 49.96M in
debt, giving a net cash position of -19.54M.
Cash & Cash Equivalents 30.42M Total Debt 49.96M Net Cash -19.54M Retained Earnings -2.52B Total Assets 112.27M Working Capital 18.23M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -81.19M
and capital expenditures -25M, giving a free cash flow of -106.19M.
Operating Cash Flow -81.19M Capital Expenditures -25M Free Cash Flow -106.19M FCF Per Share -0.93
Full Cash Flow Statement Margins Gross margin is 93.49%, with operating and profit margins of -147.91% and -168.76%.
Gross Margin 93.49% Operating Margin -147.91% Pretax Margin -172.37% Profit Margin -168.76% EBITDA Margin -148.02% EBIT Margin -147.91% FCF Margin -196.85%
Dividends & Yields CTIC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CTIC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 3, 2017. It was a
backward
split with a ratio of 1:10.
Last Split Date Jan 3, 2017 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -27.06 Piotroski F-Score 3
